Schrodinger (SDGR) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Schrodinger (SDGR) do?
Schrodinger Inc (SDGR) is a U.S.-listed company in Healthcare (Health Information Services). What it does: Licenses physics-based software platforms to biopharmaceutical and industrial companies for molecular modeling. Simulates molecular interactions with physics-based software to speed up drug discovery and materials design. It is worth $1.98B on the market and sold $269.05M over the last year.
- Market cap
- $1.98B
- P/E ratio
- None (reported a loss)
- Annual sales
- $269.05M
- Sector
- Healthcare
- Industry
- Health Information Services
- Brief updated
- Nov 17, 2026
Brands and businesses behind SDGR
- PyMOL: Molecular visualization system sold via paid licenses to structural biologists and research organizations.
- LiveDesign: Collaborative enterprise software sold to biopharma teams for designing and tracking chemical compounds.
- Maestro: Unified graphical interface for accessing computational chemistry applications sold on an annual subscription basis.
SDGR’s flags, in plain English
Each flag is a number from Schrodinger’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 17, 2026.
Stupid Cash
Can pay this year's bills 2.8 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Wide Gross Margin
Gross margin of 58.5% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Still Climbing
Sales up 18.8% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Burning Cash
Losing money, profit margin of -22%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.
2 more green flags and 2 more risk notes open with the free trial. Try it free for 7 days.
Questions about SDGR
How big is Schrodinger?
Schrodinger’s market cap is $1.98B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $269.05M: what customers paid the company over the last year, before any costs.
What is SDGR’s P/E ratio?
SDGR has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with SDGR?
Software licensing revenue relies heavily on biotechnology research budgets that decline during industry downturns. That is one risk on Schrodinger’s card. Its first risk flag is Burning Cash, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Schrodinger’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. SDGR’s filings on SEC.gov. The Margin Monkey is research, not advice.
